Wordt geladen...

Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets

Walking impairment is a clinical hallmark of multiple sclerosis (MS) that has been under-recognized as a therapeutic target for pharmacologic intervention. The development and approval of dalfampridine extended release tablets (dalfampridine-ER; known as prolonged-, modified, or sustained-release fa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Degener Neurol Neuromuscul Dis
Hoofdauteurs: Henney, Herbert R, Blight, Andrew R
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2012
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6065578/
https://ncbi.nlm.nih.gov/pubmed/30890878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S19839
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!